Among these, FLCN has been suspected to be a tumor suppressor gene whose inactivation by mutations is causative of Birt-Hogg-Dubé syndrome, whose symptoms include susceptibility to renal cancers [45]. This evidence concerns the gene FLCN and Birt-Hogg-Dubé syndrome.